Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07181876 · ClinicalTrials.gov registry record
Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System
A clinical trial of Inguinal Hernia Repair, sponsored by Distalmotion.
- Recruiting
- Registry status
- 140
- Enrollment target
- 2
- Study locations
NCT07181876 is a study of Inguinal Hernia Repair that is actively recruiting participants, run by Distalmotion. The registered enrollment target is 140 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT07181876, a study of Inguinal Hernia Repair, is actively recruiting participants, sponsored by Distalmotion.
- RECRUITING
- Registry status
- 140 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this post-market, observational study is to collect data under anticipated conditions of use that demonstrates that DEXTER performs as intended in the intended patient population, including a variety of representative disease etiologies and demographic groups.
Conditions Studied
Interventions
- DEVICE inguinal hernia repair
Study Locations (2)
New York
- Northtowns Ambulatory Surgical Center (NASC) - Buffalo
Texas
- Memorial Hermann-Texas Medical Center - UT Health Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2025-11-26 |
| Est. Completion | 2029-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07181876
The ClinicalTrials.gov registry entry for NCT07181876 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Distalmotion, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inguinal Hernia Repair appearing as the primary indexed condition, and to 1 intervention - of which inguinal hernia repair is the first listed.
NCT07181876 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Texas.
Frequently Asked Questions
What is clinical trial NCT07181876 about?
NCT07181876 is a clinical study titled "Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System". The purpose of this post-market, observational study is to collect data under anticipated conditions of use that demonstrates that DEXTER performs as intended in the intended patient population, including a variety of representative disease etiologies and demographic groups.
What is the current status of trial NCT07181876?
This trial is currently recruiting. The enrollment target is 140 participants. The study started on 2025-11-26. Estimated completion is 2029-12.
What conditions does trial NCT07181876 study?
This clinical trial studies the following conditions: Inguinal Hernia Repair.
What interventions are being tested in trial NCT07181876?
The interventions under investigation include: inguinal hernia repair (DEVICE).
Who is sponsoring clinical trial NCT07181876?
This trial is sponsored by Distalmotion, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07181876 being conducted?
This trial has 2 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inguinal Hernia Repair
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.